A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis.
Shin-Ichiro Imai
文献索引:Pharmacol. Res. 62(1) , 42-7, (2010)
全文:HTML全文
摘要
Aging science has recently drawn much attention, and discussions on the possibility of anti-aging medicine have multiplied. One potential target for the development of anti-aging drugs is the SIR2 (silent information regulator 2) family of NAD-dependent deacetylases/ADP-ribosyltransferases, called "sirtuins." Sirtuins regulate many fundamental biological processes in response to a variety of environmental and nutritional stimuli. In mammals, the mammalian SIR2 ortholog SIRT1 has been most studied, and small molecule SIRT1 activators (STACs), including a plant-derived polyphenolic compound resveratrol, have been developed. On the other hand, sirtuin activity is regulated by NAD biosynthetic pathways, and nicotinamide phosphoribosyltransferase (NAMPT) plays a critical role in the regulation of mammalian sirtuin activity. Recent studies have provided a proof of concept for the idea that nicotinamide mononucleotide (NMN), the NAMPT reaction product, can be used as a nutriceutical to activate SIRT1 activity. Based on these recent findings, the possibility of sirtuin-targeted nutriceutical development will be discussed.Copyright 2010 Elsevier Ltd. All rights reserved.
相关化合物
相关文献:
2015-11-15
[J. Immunol. 195 , 4999-5010, (2015)]
2012-01-01
[Biochem. J. 441(1) , 131-41, (2012)]
2011-01-01
[PLoS ONE 6(8) , e22781, (2011)]
2011-12-01
[Diabetologia 54(12) , 3083-92, (2011)]
2009-05-15
[Biochem. Pharmacol. 77(10) , 1612-20, (2009)]